Crystal structure of CmlI, the arylamine oxygenase from the chloramphenicol biosynthetic pathway

Cory J. Knoot, Elena G. Kovaleva, John D. Lipscomb

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The diiron cluster-containing oxygenase CmlI catalyzes the conversion of the aromatic amine precursor of chloramphenicol to the nitroaromatic moiety of the active antibiotic. The X-ray crystal structures of the fully active, N-terminally truncated CmlIΔ33 in the chemically reduced Fe2+/Fe2+ state and a cisμ-1,2(η11)-peroxo complex are presented. These structures allow comparison with the homologous arylamine oxygenase AurF as well as other types of diiron cluster-containing oxygenases. The structural model of CmlIΔ33 crystallized at pH 6.8 lacks the oxo-bridge apparent from the enzyme optical spectrum in solution at higher pH. In its place, residue E236 forms a μ-1,3(η12) bridge between the irons in both models. This orientation of E236 stabilizes a helical region near the cluster which closes the active site to substrate binding in contrast to the open site found for AurF. A very similar closed structure was observed for the inactive dimanganese form of AurF. The observation of this same structure in different arylamine oxygenases may indicate that there are two structural states that are involved in regulation of the catalytic cycle. Both the structural studies and single crystal optical spectra indicate that the observed cis μ-1,2(η11)-peroxo complex differs from the μ-η12-peroxo proposed from spectroscopic studies of a reactive intermediate formed in solution by addition of O2 to diferrous CmlI. It is proposed that the structural changes required to open the active site also drive conversion of the µ-1,2-peroxo species to the reactive form.

Original languageEnglish (US)
Pages (from-to)589-603
Number of pages15
JournalJournal of Biological Inorganic Chemistry
Volume21
Issue number5-6
DOIs
StatePublished - Sep 1 2016

Fingerprint

Oxygenases
Biosynthetic Pathways
Chloramphenicol
Crystal structure
Catalytic Domain
Structural Models
Amines
Observation
X-Rays
Single crystals
Iron
Anti-Bacterial Agents
X rays
Substrates
Enzymes

Keywords

  • Antibiotic biosynthesis
  • Arylamine oxygenase
  • Diiron cluster
  • Non-heme iron
  • Oxygen activation
  • Peroxo intermediate

Cite this

Crystal structure of CmlI, the arylamine oxygenase from the chloramphenicol biosynthetic pathway. / Knoot, Cory J.; Kovaleva, Elena G.; Lipscomb, John D.

In: Journal of Biological Inorganic Chemistry, Vol. 21, No. 5-6, 01.09.2016, p. 589-603.

Research output: Contribution to journalArticle

@article{c6aa0821cdc24fd68a0c96202999d436,
title = "Crystal structure of CmlI, the arylamine oxygenase from the chloramphenicol biosynthetic pathway",
abstract = "The diiron cluster-containing oxygenase CmlI catalyzes the conversion of the aromatic amine precursor of chloramphenicol to the nitroaromatic moiety of the active antibiotic. The X-ray crystal structures of the fully active, N-terminally truncated CmlIΔ33 in the chemically reduced Fe2+/Fe2+ state and a cisμ-1,2(η1:η1)-peroxo complex are presented. These structures allow comparison with the homologous arylamine oxygenase AurF as well as other types of diiron cluster-containing oxygenases. The structural model of CmlIΔ33 crystallized at pH 6.8 lacks the oxo-bridge apparent from the enzyme optical spectrum in solution at higher pH. In its place, residue E236 forms a μ-1,3(η1:η2) bridge between the irons in both models. This orientation of E236 stabilizes a helical region near the cluster which closes the active site to substrate binding in contrast to the open site found for AurF. A very similar closed structure was observed for the inactive dimanganese form of AurF. The observation of this same structure in different arylamine oxygenases may indicate that there are two structural states that are involved in regulation of the catalytic cycle. Both the structural studies and single crystal optical spectra indicate that the observed cis μ-1,2(η1:η1)-peroxo complex differs from the μ-η1:η2-peroxo proposed from spectroscopic studies of a reactive intermediate formed in solution by addition of O2 to diferrous CmlI. It is proposed that the structural changes required to open the active site also drive conversion of the µ-1,2-peroxo species to the reactive form.",
keywords = "Antibiotic biosynthesis, Arylamine oxygenase, Diiron cluster, Non-heme iron, Oxygen activation, Peroxo intermediate",
author = "Knoot, {Cory J.} and Kovaleva, {Elena G.} and Lipscomb, {John D.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1007/s00775-016-1363-x",
language = "English (US)",
volume = "21",
pages = "589--603",
journal = "Journal of Biological Inorganic Chemistry",
issn = "0949-8257",
publisher = "Springer Verlag",
number = "5-6",

}

TY - JOUR

T1 - Crystal structure of CmlI, the arylamine oxygenase from the chloramphenicol biosynthetic pathway

AU - Knoot, Cory J.

AU - Kovaleva, Elena G.

AU - Lipscomb, John D.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The diiron cluster-containing oxygenase CmlI catalyzes the conversion of the aromatic amine precursor of chloramphenicol to the nitroaromatic moiety of the active antibiotic. The X-ray crystal structures of the fully active, N-terminally truncated CmlIΔ33 in the chemically reduced Fe2+/Fe2+ state and a cisμ-1,2(η1:η1)-peroxo complex are presented. These structures allow comparison with the homologous arylamine oxygenase AurF as well as other types of diiron cluster-containing oxygenases. The structural model of CmlIΔ33 crystallized at pH 6.8 lacks the oxo-bridge apparent from the enzyme optical spectrum in solution at higher pH. In its place, residue E236 forms a μ-1,3(η1:η2) bridge between the irons in both models. This orientation of E236 stabilizes a helical region near the cluster which closes the active site to substrate binding in contrast to the open site found for AurF. A very similar closed structure was observed for the inactive dimanganese form of AurF. The observation of this same structure in different arylamine oxygenases may indicate that there are two structural states that are involved in regulation of the catalytic cycle. Both the structural studies and single crystal optical spectra indicate that the observed cis μ-1,2(η1:η1)-peroxo complex differs from the μ-η1:η2-peroxo proposed from spectroscopic studies of a reactive intermediate formed in solution by addition of O2 to diferrous CmlI. It is proposed that the structural changes required to open the active site also drive conversion of the µ-1,2-peroxo species to the reactive form.

AB - The diiron cluster-containing oxygenase CmlI catalyzes the conversion of the aromatic amine precursor of chloramphenicol to the nitroaromatic moiety of the active antibiotic. The X-ray crystal structures of the fully active, N-terminally truncated CmlIΔ33 in the chemically reduced Fe2+/Fe2+ state and a cisμ-1,2(η1:η1)-peroxo complex are presented. These structures allow comparison with the homologous arylamine oxygenase AurF as well as other types of diiron cluster-containing oxygenases. The structural model of CmlIΔ33 crystallized at pH 6.8 lacks the oxo-bridge apparent from the enzyme optical spectrum in solution at higher pH. In its place, residue E236 forms a μ-1,3(η1:η2) bridge between the irons in both models. This orientation of E236 stabilizes a helical region near the cluster which closes the active site to substrate binding in contrast to the open site found for AurF. A very similar closed structure was observed for the inactive dimanganese form of AurF. The observation of this same structure in different arylamine oxygenases may indicate that there are two structural states that are involved in regulation of the catalytic cycle. Both the structural studies and single crystal optical spectra indicate that the observed cis μ-1,2(η1:η1)-peroxo complex differs from the μ-η1:η2-peroxo proposed from spectroscopic studies of a reactive intermediate formed in solution by addition of O2 to diferrous CmlI. It is proposed that the structural changes required to open the active site also drive conversion of the µ-1,2-peroxo species to the reactive form.

KW - Antibiotic biosynthesis

KW - Arylamine oxygenase

KW - Diiron cluster

KW - Non-heme iron

KW - Oxygen activation

KW - Peroxo intermediate

UR - http://www.scopus.com/inward/record.url?scp=84969921626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969921626&partnerID=8YFLogxK

U2 - 10.1007/s00775-016-1363-x

DO - 10.1007/s00775-016-1363-x

M3 - Article

C2 - 27229511

AN - SCOPUS:84969921626

VL - 21

SP - 589

EP - 603

JO - Journal of Biological Inorganic Chemistry

JF - Journal of Biological Inorganic Chemistry

SN - 0949-8257

IS - 5-6

ER -